SPX4,207.27-2.97 -0.07%
DIA333.71+0.51 0.15%
IXIC12,779.91-74.89 -0.58%

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

MT Newswires · 07/28/2022 06:09

Please log in to view news